Dr. Rebecca Kate Miller-Kuhlmann, MD

Dr. Miller-Kuhlmann practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Miller-Kuhlmann's NPI, 1417290867, was assigned on April 4, 2013. Dr. Miller-Kuhlmann graduated from UCSF School of Medicine in 2013. Dr. Miller-Kuhlmann holds California license A133352.

Dr. Miller-Kuhlmann's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Miller-Kuhlmann's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Miller-Kuhlmann to 1 more hospital and 1 medical group, each named with a free account. Dr. Miller-Kuhlmann's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller-Kuhlmann practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Miller-Kuhlmann's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Miller-Kuhlmann is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Miller-Kuhlmann is licensed in California.

Dmand AI lists alzheimer's disease, essential tremor, fibromyalgia and chronic pain, lower back pain, migraine and chronic headache, mobility impairment, nerve damage and non-alzheimer's dementia (chronic) among the conditions Dr. Miller-Kuhlmann treats.

CMS data shows 417 Medicare services from Dr. Miller-Kuhlmann across 9 procedure codes in 2024, for 102 Medicare patients. Medicare paid $30,922 for them.

CMS counts 102 Medicare patients who saw Dr. Miller-Kuhlmann in 2024. The largest group is 65 to 74, with 32 patients. 67% of them have high cholesterol, and 64% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miller-Kuhlmann's median patient age at 59, with 66% women.

In 2024, Dr. Miller-Kuhlmann wrote 454 Medicare Part D claims for 66 patients. 88% of them were for generic drugs. CMS names the drug for 300 of them, across 13 drugs with 11 or more claims each, at $54,464 in total drug cost. In 2023, CMS named 272 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Miller-Kuhlmann for performance year 2024, reported as part of a group. Dr. Miller-Kuhlmann accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miller-Kuhlmann as offering telehealth.

Dmand AI links 12 papers to Dr. Miller-Kuhlmann, published from 2020 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Internship and Residency, Mentoring and Communication. Dr. Miller-Kuhlmann has published most often in BMC Med Educ. Dr. Miller-Kuhlmann's most frequent co-authors are Carl Aaron Gold, MD, Aussama Khalaf Nassar, MD and Rebecca Leanne Blankenburg, MD.

Dr. Miller-Kuhlmann graduated from UCSF School of Medicine in 2013.

Dr. Miller-Kuhlmann is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.